The study shows that the prevalence of NTM pulmonary diseases-associated hospitalisations is steadily increasing in Germany with COPD being currently the most important associated condition. This population-based study provides evidence of a changing epidemiology of NTM pulmonary diseases in Germany as it has already been shown in the US and highlights emerging clinical implications.

PubMed Link

BMC Infectious Diseases Full Text